Fairfield, Bush & Co’s Columbia Research Enhanced Value ETF REVS Stock Holding History
Bought
Maintained
Sold
Other funds holding REVS
CA
NA
PVI
HGERS
Fairfield, Bush & Co's REVS Position: Q1 2024 in Review
Fairfield, Bush & Co sold out of Columbia Research Enhanced Value ETF (REVS) in Q1 2024, closing a stake of 23 shares — an estimated $498 sold.
Fairfield, Bush & Co first reported a position in REVS in Q2 2023 and held it in 2 quarters. The position peaked at $522 in Q2 2023. 16 funds tracked by Wall St. Rank hold REVS as of Q1 2024.
- Fairfield, Bush & Co reported no remaining Columbia Research Enhanced Value ETF position as of Q1 2024 after selling out during the quarter.
- Fairfield, Bush & Co sold 23 Columbia Research Enhanced Value ETF shares in Q1 2024, an estimated $498.
- Fairfield, Bush & Co first reported a position in Columbia Research Enhanced Value ETF in Q2 2023 and held it in 2 quarters.
- Fairfield, Bush & Co's Columbia Research Enhanced Value ETF position peaked at $522 in Q2 2023.
- 16 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q1 2024.
Based on Fairfield, Bush & Co's 13F filing for Q1 2024, filed 15 May 2024.